Laboratory of Genitourinary Cancer Pathogenesis


LGCP Branch 2022
Laboratory of Genitourinary Cancer Pathogenesis, May 2022

The Laboratory of Genitourinary Cancer Pathogenesis (LGCP) focuses on genitourinary (GU) cancers, especially prostate cancer, with the goal of understanding fundamental processes of cancer pathogenesis and translating this knowledge into clinical applications. We work within the Urologic Oncology Collaborative Group, which brings together integrated basic and translational research, surgical oncology, and medical oncology for the purpose of improving the detection, diagnosis, and treatment of patients with GU cancers. Specifically, LGCP includes mechanism-oriented research programs to investigate 1) the action of common prostate cancer genomic mutations, 2) microenvironmental influences on tumor progression and metastasis development, 3) castration resistance and prostate cancer stem cells, and 4) the regulation of responses to cell death pathways.

Job Vacancies

Position Degree Required Contact Name Contact Email
Post-doctoral Fellow - Prostate cancer, translational research Ph.D. or equivalent Adam Sowalsky
Post-doctoral Fellow - Epigenetics, functional genomics, cancer Ph.D. or equivalent David Takeda


Contact Info

Center for Cancer Research National Cancer Institute

  • Building 37, Room 1068
  • Bethesda, MD 20892-4263
  • 240-760-6827
Lei Fang, Ph.D.
Technical Lab Manager
Lei Fang, Ph.D.
Takisha Peterson
Program Specialist
Takisha Peterson